1 active not recruiting, 1 completed, 1 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Lumigan: new trials by email Literature Review of Lumigan trials Research Report on Lumigan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension AGN-193408 SR, Lumigan, Sham Administration - Open-angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | Active not recruiting | AbbVie | 100 | 2020-11-16 | 2026-05-22 |
| Topical Bimatoprost in the Treatment of Migraine Bimatoprost Topical Solution, Control - Migraine Disorders, Headache Disorders | Phase 2 | Unknown | Manistee Partners | 70 | 2018-01-05 | 2019-04-26 |
| A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension Fixed-Combination Bimatoprost/Brimonidine, Bimatoprost Ophthalmic Solution 0.01%, Vehicle Ophthalmic Solution - Glaucoma, Ocular Hypertension | Phase 2 | Completed | Allergan | 112 | 2013-06-01 | 2015-01-26 |
Ocular Hypertension (2) · Glaucoma (1) · Glaucoma, Open-Angle (1) · Headache (1) · Headache Disorders (1) · Migraine Disorders (1)
AbbVie (1) · Allergan (1) · Manistee Partners (1)
United States (3) · Japan (1)